Publicacions (53) Publicacions en què ha participat algun investigador/a

filter_list General%20Pharmacology,%20Toxicology%20and%20Pharmaceutics

2025

  1. Chronic mild stress dysregulates autophagy, membrane dynamics, and lysosomal status in frontal cortex and hippocampus of rats

    European Neuropsychopharmacology, Vol. 94, pp. 24-35

  2. Genome sequences of four Ixodes species expands understanding of tick evolution

    BMC biology, Vol. 23, Núm. 1, pp. 17

2024

  1. A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma

    Translational Research, Vol. 272, pp. 95-110

  2. Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition

    Nature Communications , Vol. 15, Núm. 1

  3. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

    Neuro-Oncology, Vol. 26, Núm. 7, pp. 1230-1246

  4. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth

    Cancer Letters, Vol. 591

  5. The Gap Junction Inhibitor Octanol Decreases Proliferation and Increases Glial Differentiation of Postnatal Neural Progenitor Cells

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

2023

  1. Antiproliferative effect of boldine on neural progenitor cells and on glioblastoma cells

    Frontiers in Neuroscience, Vol. 17

  2. Elevated FOXG1 in glioblastoma stem cells cooperates with Wnt/β-catenin to induce exit from quiescence

    Cell Reports, Vol. 42, Núm. 6

  3. Impact of reflex locomotion and the Bobath concept on clinical and biomolecular parameters in people with multiple sclerosis: study protocol for a randomized controlled trial

    Frontiers in Neurology, Vol. 14

  4. Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

    Journal of Visualized Experiments, Vol. 2023, Núm. 196

  5. Metabolic remodeling in astrocytes: Paving the path to brain tumor development

    Neurobiology of Disease, Vol. 188

2022

  1. Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Src: coordinating metabolism in cancer

    Oncogene, Vol. 41, Núm. 45, pp. 4917-4928

2021

  1. Efecto de la región de conexina43 inhibidora de Src en células madre de cáncer de pulmón

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 51

  2. Efecto del péptido antitumoral TAT-Cx43266-283 en células madre neurales en un modelo de glioma in vivo

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 84

  3. Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))

    EBioMedicine

  4. Erratum: Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo (Neuro-Oncology DOI: 10.1093/neuonc/noz243)

    Neuro-Oncology

  5. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion

    Cell, Vol. 184, Núm. 9, pp. 2454-2470.e26

  6. Impairment of autophagic flux participates in the antitumor effects of tat-cx43266-283 in glioblastoma stem cells

    Cancers, Vol. 13, Núm. 17